Skip to content
Back to announcement

Surat Pernyataan Direksi untuk LK e sign dirut-r.pdf

Financial statement Text extracted INAF

Source file signed link, expires in 15 minutes

This browser can't display the PDF inline. Open it in a new tab.

Extracted text 1

Page 1 OCR 0.892
SURAT PERNYATAAN DIREKSI

TENTANG TANGGUNG JAWAB ATAS

LAPORAN KEUANGAN

TANGGATI, 30 SEPTEMBER 2025

DAN UNTUK PERIODE SEMBILAN BULAN YANG
BERAKHIR PADA TANGGAL TERSEBUT

PT INDOFARMA Tbk

Kami yang bertanda tangan di bawah ini:

(/
indofarma

Member of Biofarma Graup

DIRECTORS' STATEMENT LETTER

REGARDING TINE RESPONSIBILITY FOR
THE FINANCIAL STATEMENTIS

AS OF SEPTEMBER 30, 2025

AND FOR THE NINE-MONTH

PERIOD THEN ENDED

PT INDOFARMA Tbk

We, Ihe undersigned :

Nama Sahat Sihombing Name
Alamat Kantor Jl. Indofarma No. 1, Cikarang Barat 17530 Official Address
NIK 3175022310660002 ID Number
Jabatan Direktur Utama / President Director Position

Menyatakan bahwa :

I. Kami bertanggung jawab atas penyusunan dan penyajian
laporan keuangan PT Indofarma Tbk,

2. Laporan keuangan PT Indofarma Tbk telah disusun dan
disajikan sesuai dengan Standar Akuntansi Keuangan di
Indonesia:

Semua informasi dalam laporan kenangan PT
Indofarma Tbk telah dimuat secara lengkap dan
benar:

b. Laporan keuangan PT Indofarma Tbk tidak
mengandung informasi atau fakta material yang
tidak benar, dan tidak menghilangkan informasi atau
fakta material:

4. Kami bertanggung jawab atas sistem pengendalian
internal dalam PT Indofarma Tbk.

Demikian pernyataan ini dibuat dengan sebenarnya.

State that :

1

3.

We are responsible for preparation and presentation of"
Ihe financial statements of PT Indofarma Tbk:

The financial statements of PT Indofarma Tbk have
been prepared and presented in accordance with
Indonesian Financial Accounting Standards:

a. All information contained in Ihe financial
statements of PT Indofarma Tbk is complete and
correct,

b. The financial statements of PT Indofarma Tbk do
not contain misleading material information or
facts, and do not omit material information and
facts:

We are responsible for Ihe internal control system of PT'
Indofarma Tbk.

This statemeni letter is made truthfully.

Jakarta, 28 Oktober 2025 / October 28, 2025
PT Indofarma Tbk

Direktur Utama
/ Prefident Director Y

TAN, XO70575723
Ae

PT Indofarma Tbk
JL. Indofarma No.1, Cikarang Barat
Bekasi 17530 - Indonesia

Ph. G2-21-88323971/75
Fx. 62-21-88323972/73

Email: headoffice@indofarma.id
www.indofarma.id

File

File Open PDF
Source IDX
Size0.26 MB
Published31 Oct 2025
Pages1
Characters2,209
Text sourceOCR
OCR confidence0.892

Names mentioned 2 people and organisations named in the text · linked when the evidence is strong

linked person Sahat Sihombing p.1
possible org INDOFARMA Tbk p.1 ×27

Extraction attempts how the parser did, and what it refused

Nothing structured was extracted from this document — the attempts below say why.

No extraction attempted yet.

Other files in this announcement 6

FinancialStatement-2025-III-INAF.xlsx done
inlineXBRL.zip done
↑↓ select ↵ open ⇧↵ see every result